Condition
Malaria Prevention
Total Trials
5
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
Early P 1 (1)
P 1 (1)
P 2 (1)
Trial Status
Not Yet Recruiting4
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07548021Phase 1Not Yet Recruiting
Safety and PK of MMV371 LAI in Healthy Adults and Adolescents in Rwanda
NCT07021430Early Phase 1Not Yet RecruitingPrimary
Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy
NCT07387341Not ApplicableNot Yet Recruiting
Long-acting Spatial Emanators / Repellents (LASER)
NCT07373301Phase 2Not Yet Recruiting
Phase IIa/b Trial of PvCS/Montanide ISA-51 Malaria Vaccine in Adults in Chocó, Colombia
NCT01829815Not ApplicableCompleted
Impact of a Parenting Program in Liberia to Improve Parenting, Education, and Health Outcomes for Children in Liberia
Showing all 5 trials